0000899243-23-012086.txt : 20230503
0000899243-23-012086.hdr.sgml : 20230503
20230503162259
ACCESSION NUMBER: 0000899243-23-012086
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230503
FILED AS OF DATE: 20230503
DATE AS OF CHANGE: 20230503
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Sullivan Timothy Eugene
CENTRAL INDEX KEY: 0001707000
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38276
FILM NUMBER: 23884375
MAIL ADDRESS:
STREET 1: 800 BOYLSTON ST., SUITE 3310
STREET 2: PRUDENTIAL TOWER C/O AJU IB INVESTMENT
CITY: BOSTON
STATE: MA
ZIP: 02199
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Apellis Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001492422
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 271537290
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 100 FIFTH AVENUE
CITY: WALTHAM
STATE: MA
ZIP: 02451
BUSINESS PHONE: 617-977-5700
MAIL ADDRESS:
STREET 1: 100 FIFTH AVENUE
CITY: WALTHAM
STATE: MA
ZIP: 02451
4
1
doc4.xml
FORM 4 SUBMISSION
X0407
4
2023-05-03
0
0001492422
Apellis Pharmaceuticals, Inc.
APLS
0001707000
Sullivan Timothy Eugene
C/O APELLIS PHARMACEUTICALS, INC.
100 FIFTH AVENUE, 3RD FLOOR
WALTHAM
MA
02451
0
1
0
0
Chief Financial Officer
0
Common Stock
2023-05-03
4
G
0
20000
0.00
D
77713
D
Common Stock
2023-05-03
4
G
0
20000
0.00
A
56232
I
Indirect Owner (The Timothy E Sullivan Irrevocable Trust of 2023)
On May 3, 2023, the reporting person transferred 20,000 shares to The Timothy E Sullivan Irrevocable Trust of 2023. Patrick O. Collins is the trustee of The Timothy E Sullivan Irrevocable Trust of 2023. The reporting person disclaims beneficial ownership over the shares held by The Timothy E Sullivan Irrevocable Trust of 2023 except to the extent of his pecuniary interest therein.
/s/ David Watson, attorney-in-fact for Timothy Sullivan
2023-05-03